Skip to main content

Advertisement

SpringerLink
Log in

Tuberculosis: the story after the Primer

  • Comment
  • Published:

From Nature Reviews Disease Primers

View current issue Sign up to alerts

Collaboration between authors and journal staff can contribute to expand the reach of Primers, including to areas where they would be most useful.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Pai, M. et al. Tuberculosis. Nat. Rev Dis Primers 2, 1–23 (2016).

    Article  Google Scholar 

  2. World Health Organization. Global Tuberculosis Report 2019. who.com https://www.who.int/tb/global-report-2019(2019).

  3. Van Der Meeren, O. et al. Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis. N. Engl. J. Med. 379, 1621–1634 (2018).

    Article  Google Scholar 

  4. US Food & Drug Administration. FDA approves new drug for treatment-resistant forms of tuberculosis that affects the lungs. fda.gov https://www.fda.gov/news-events/press-announcements/fda-approves-new-drug-treatment-resistant-forms-tuberculosis-affects-lungs (2019).

  5. Swindells, S. et al. One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis. N. Engl. J. Med. 380, 1001–1011 (2019).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. McGill International Tuberculosis Centre, McGill University, Montreal, Québec, Canada

    Madhukar Pai

  2. Manipal McGill Program for Infectious Diseases, Manipal Centre for Infectious Diseases, Manipal Academy of Higher Education, Manipal, India

    Madhukar Pai

Authors
  1. Madhukar Pai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Madhukar Pai.

Ethics declarations

Competing interests

The author declares no competing interests.

Additional information

Related links

Nature Microbiology Community blog: https://naturemicrobiologycommunity.nature.com/users/20892-madhukar-pai/posts/12911-first-primer-on-tuberculosis-in-nature-reviews-disease-primers

Research4Life: https://www.research4life.org/

SharedIt: https://www.springernature.com/gp/researchers/sharedit

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pai, M. Tuberculosis: the story after the Primer. Nat Rev Dis Primers 6, 29 (2020). https://doi.org/10.1038/s41572-020-0161-5

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/s41572-020-0161-5

  • Springer Nature Limited

Search

Navigation